Hyperoxaluria Type 1 | List of Frontiers open access articles

Brief Research Report

Published on 22 Feb 2024

Bone health in children with primary hyperoxaluria type 1 following liver and kidney transplantation

in Pediatric Nephrology

Rainer Büscher
Lars Pape
Anja K. Büscher

Frontiers in Pediatrics

doi 10.3389/fped.2024.1353880

2,729 views
4 citations

Case Report

Published on 05 Jan 2022

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1

in Pediatric Nephrology

Benedetta Chiodini
Nathalie Tram
Brigitte Adams
Elise Hennaut
Ksenija Lolin
Khalid Ismaili

Frontiers in Pediatrics

doi 10.3389/fped.2021.791616

3,569 views
9 citations

Original Research

Published on 17 Mar 2023

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1

in Pediatric Nephrology

Sebastian Loos
Markus J. Kemper
Kaja Schmaeschke
Uta Herden
Lutz Fischer
Bernd Hoppe
Tanja Kersnik Levart
Enke Grabhorn
Raphael Schild
Jun Oh

Frontiers in Pediatrics

doi 10.3389/fped.2023.1157215

3,584 views
9 citations

Case Report

Published on 16 Jan 2024

Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1

in Pediatric Nephrology

Francesca Taroni
Alfredo Berrettini
Michele Gnech
Francesca Rella
Gian Antonio Manzoni
Giovanni Montini

Frontiers in Pediatrics

doi 10.3389/fped.2023.1338909

3,205 views
3 citations

Review

Published on 10 Jan 2023

Lumasiran for primary hyperoxaluria type 1: What we have learned?

in Pediatric Nephrology

Xuan Gang
Fei Liu
Jianhua Mao

Frontiers in Pediatrics

doi 10.3389/fped.2022.1052625

10,214 views
24 citations

Original Research

Published on 06 Feb 2019

Two Novel AGXT Mutations Cause the Infantile Form of Primary Hyperoxaluria Type I in a Chinese Family: Research on Missed Mutation

in Translational Pharmacology

Xiulan Lu
Weijian Chen
Liping Li
Xinyuan Zhu
Caizhi Huang
Saijun Liu
Yongjia Yang
Yaowang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00085

5,787 views
9 citations

Original Research

Published on 20 Sep 2021

Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study

in Nephrology

Xiangling Wang
David Danese
Thomas Brown
Jessica Baldwin
Gautam Sajeev
Erin E. Cook
Yao Wang
Chunyi Xu
Hongbo Yang
Michael L. Moritz

Frontiers in Medicine

doi 10.3389/fmed.2021.703305

8,991 views
12 citations

Clinical Trial

Published on 16 Sep 2024

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial

in Pediatric Nephrology

Yaacov Frishberg
Wesley Hayes
Hadas Shasha-Lavsky
David J. Sas
Mini Michael
Anne-Laure Sellier-Leclerc
Julien Hogan
Richard Willey
John M. Gansner
Daniella Magen

Frontiers in Pediatrics

doi 10.3389/fped.2024.1392644

5,093 views
8 citations

Original Research

Published on 09 Apr 2021

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis

in Nephrology

David J. Sas
Felicity T. Enders
Tina M. Gunderson
Ramila A. Mehta
Julie B. Olson
Barbara M. Seide
Carly J. Banks
Bastian Dehmel
Patricia A. Pellikka
John C. Lieske

Frontiers in Medicine

doi 10.3389/fmed.2021.592357

3,658 views
11 citations

Articles

Bone health in children with primary hyperoxaluria type 1 following liver and kidney transplantation

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1

Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1

Lumasiran for primary hyperoxaluria type 1: What we have learned?

Two Novel AGXT Mutations Cause the Infantile Form of Primary Hyperoxaluria Type I in a Chinese Family: Research on Missed Mutation

Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis